Gaush Meditech Ltd (2407) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Gaush Meditech Ltd stock HK$12.30, price HK$4.90, upside +151.3%, quality 58 out of 100. Rating: strongly undervalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Gaush Meditech Ltd
2407 · HKCheap (60% below fair value) and solid company, but falling price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.
How to read this chart
47‑month range HK$3.88 – HK$48.87 · fair‑value band HK$9.20 – HK$16.33 · the HK$4.90 price screens below the HK$12.30 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.
Every Wednesday you see whether Gaush Meditech is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers.
Show moreShow less
The company's product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, refractive surgery, glaucoma, ocular surface diseases, optometry, and pediatric ophthalmology.
The company was founded in 1998 and is headquartered in Beijing, China.
Stock analysis
Gaush Meditech Ltd (2407) currently trades at HK$4.90, while our model-based Fair Value estimate is HK$12.30, implying the stock looks roughly 60% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of HK$15.26 per share, and 23 of the 24 models we run sit above the HK$4.90 price.
Bear case: the Economic Profit group reads lowest at HK$8.14, and 1 of the 24 models stay below the price. Data coverage for this calculation is low.
Scenario range: HK$9.20 (bear) to HK$16.33 (bull), the price of HK$4.90 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 58/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Gaush Meditech Ltd reported revenue of 1.4B CNY in FY2025 versus 1.3B CNY in FY2021, a compound +1.5%/yr. Reported net income was 96.2M CNY in FY2025.
Key figures
Market cap HK$700M (≈ $89.2M) Micro · P/E ratio 6.9 · P/S ratio 0.48 · Net margin 7.0% · Return on equity 4.2% · Return on assets (EBIT) 8.4% (5-year average) · Operating margin 6.6% · Revenue (TTM) 1.3B CNY.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 47% below its 52-week high and 26% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 7% fair-value upside, at 151%, 2407 screens cheaper than that median.
Fair Value models
All 24 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch 2407, get fair value alerts →
Compare Gaush Meditech Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 401 stocks
Valuation Multiplesvs Medical Devices median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Net margin by industry
- P/B ratio by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Hong Kong Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Stryker Corporation SYK | $309.64 | $340.60 | +10% | vs 2407 |
| Boston Scientific Corporation BSX | $44.34 | $48.77 | +10% | vs 2407 |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥179.40 | ¥197.34 | +10% | vs 2407 |
| DexCom, Inc DXCM | $83.33 | $91.66 | +10% | vs 2407 |
| STERIS plc STE | $264.32 | $281.90 | +7% | vs 2407 |
| GE HealthCare Technologies Inc GEHC | $83.02 | $69.92 | −16% | vs 2407 |
| Edwards Lifesciences Corporation EW | $107.15 | $81.94 | −24% | vs 2407 |
| Medtronic plc MDT | $102.86 | $74.90 | −27% | vs 2407 |
| Abbott Laboratories, ABT | $108.52 | $75.28 | −31% | vs 2407 |
| Koninklijke Philips N.V PHIA | €27.43 | €15.23 | −44% | vs 2407 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Gaush Meditech Ltd (2407) overvalued or undervalued?
What is the fair value of 2407?
What is the quality score of 2407?
What is the price target for Gaush Meditech Ltd (2407)?
What is the Gaush Meditech Ltd stock forecast for 2026?
What is the revenue of Gaush Meditech Ltd (2407)?
What growth is priced into Gaush Meditech Ltd (2407)?
What discount rate (WACC) does the fair value of 2407 use?
What is a reverse DCF?
How much growth has Gaush Meditech Ltd (2407) delivered so far?
How fast is the sector of Gaush Meditech Ltd (2407) growing?
What is the free cash flow yield of Gaush Meditech Ltd (2407)?
What is the intrinsic value of Gaush Meditech Ltd (2407)?
Is Gaush Meditech Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 2407?
How much is Gaush Meditech Ltd worth?
What do the bullish and bearish scenarios say about 2407?
What is the P/E ratio of 2407?
How solid is the balance sheet of Gaush Meditech Ltd (2407)?
How far is 2407 from its 52-week high?
Which stocks are comparable to Gaush Meditech Ltd?
Is Gaush Meditech Ltd stock attractive at the current price?
How is the fair value of 2407 calculated?
Is it still worth investing in stocks now?
What is the share price of Gaush Meditech Ltd (2407)?
What should I pay attention to with Gaush Meditech Ltd right now?
Key figures of Gaush Meditech Ltd
How large is the market capitalisation of Gaush Meditech Ltd (2407)?
What is the P/S ratio of Gaush Meditech Ltd (2407)?
What is the net margin of Gaush Meditech Ltd (2407)?
What is the return on equity of Gaush Meditech Ltd (2407)?
What is the EBIT return on assets of Gaush Meditech Ltd (2407)?
What is the operating margin of Gaush Meditech Ltd (2407)?
How fast is revenue growing at Gaush Meditech Ltd (2407)?
How fast are earnings growing at Gaush Meditech Ltd (2407)?
How much net debt does Gaush Meditech Ltd (2407) carry?
Watch Gaush Meditech Ltd in the live analysis
One click puts Gaush Meditech Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.